Bombay High Court Orders FDA to Revoke Licence Suspensions After Compliance
The Bombay High Court has directed the Maharashtra Food and Drug Administration (FDA) to revoke licence suspensions once establishments rectify identified deficiencies. The court criticized delays in restoring licences despite compliance, noting financial and operational harm to businesses and their employees. It ordered fresh inspections and compliance reports, emphasizing that businesses should not be forced to approach the court to lift suspensions that no longer apply. The ruling followed a petition by a Pune-based manufacturer challenging its licence suspension.
First-hand measurement across 2 sources
We measured how 2 outlets covered this story. No outlet gave this story a measurable political slant — there is no left–right reading to report. Overall sentiment is neutral (52/100). Lens Score 54/100.
Outlets measured: hindustantimes, news18. See how each one headlined and framed the same story in the source comparison below.
AI Analysis
Sentiment was consistent across outlets (52–52/100), indicating broadly factual reporting rather than editorialising.
Coverage timeline
news18 broke this story on 7 Sept, 04:23 pm. Other outlets followed.
- 1